tradingkey.logo

Edgewise Therapeutics Provides Corporate Updates And Highlights Priorities For 2026

ReutersJan 13, 2026 1:09 PM

- Edgewise Therapeutics Inc EWTX.O:

  • EDGEWISE THERAPEUTICS PROVIDES CORPORATE UPDATES AND HIGHLIGHTS PRIORITIES FOR 2026

  • EDGEWISE THERAPEUTICS INC - ANTICIPATE PHASE 2 RESULTS FOR EDG-7500 IN HYPERTROPHIC CARDIOMYOPATHY (HCM) IN FIRST HALF OF 2026

  • EDGEWISE THERAPEUTICS INC - PREPARE FOR NDA SUBMISSION FOR SEVASEMTEN IN BECKER IN H1 2027

  • EDGEWISE THERAPEUTICS INC - TO INITIATE EDG-7500 PHASE 3 TRIAL IN INDIVIDUALS WITH OBSTRUCTIVE AND NONOBSTRUCTIVE HCM IN SECOND HALF OF 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI